LAMOTRIGINE

LAMOTRIGINE was reported 133040 times

These side effects are most commonly reported by patients taking LAMOTRIGINE:

# Side effect Count
0 DRUG INEFFECTIVE 10475
1 RASH 8746
2 SEIZURE 6895
3 NAUSEA 6504
4 OFF LABEL USE 6329
5 FATIGUE 6307
6 DIZZINESS 6143
7 HEADACHE 5871
8 DEPRESSION 5295
9 VOMITING 4890
10 SOMNOLENCE 4573
11 DRUG INTERACTION 4530
12 PYREXIA 4530
13 ANXIETY 4521
14 TOXICITY TO VARIOUS AGENTS 4374
15 CONDITION AGGRAVATED 3905
16 INSOMNIA 3894
17 PAIN 3835
18 FALL 3790
19 CONVULSION 3674
20 FOETAL EXPOSURE DURING PREGNANCY 3527
21 EPILEPSY 3502
22 DIARRHOEA 3484
23 CONFUSIONAL STATE 3398
24 COMPLETED SUICIDE 3318
25 WEIGHT INCREASED 3252
26 MALAISE 3239
27 TREMOR 3224
28 PRURITUS 3092
29 ASTHENIA 3045
30 DYSPNOEA 3029
31 SUICIDAL IDEATION 2979
32 MEMORY IMPAIRMENT 2856
33 OVERDOSE 2830
34 MATERNAL EXPOSURE DURING PREGNANCY 2826
35 STEVENS-JOHNSON SYNDROME 2673
36 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2545
37 ARTHRALGIA 2524
38 PRODUCT USE IN UNAPPROVED INDICATION 2489
39 FEELING ABNORMAL 2473
40 INTENTIONAL OVERDOSE 2371
41 SUICIDE ATTEMPT 2311
42 EXPOSURE DURING PREGNANCY 2279
43 ALOPECIA 2182
44 DRUG HYPERSENSITIVITY 2153
45 GAIT DISTURBANCE 2152
46 WEIGHT DECREASED 2049
47 HYPERTENSION 2036
48 HYPOAESTHESIA 2031
49 AGITATION 2023
50 PNEUMONIA 2008
51 DECREASED APPETITE 1972
52 MIGRAINE 1950
53 URTICARIA 1950
54 ABDOMINAL PAIN UPPER 1943
55 PARAESTHESIA 1928
56 MUSCLE SPASMS 1836
57 BALANCE DISORDER 1735
58 LOSS OF CONSCIOUSNESS 1724
59 AGGRESSION 1723
60 ERYTHEMA 1702
61 HYPERSENSITIVITY 1697
62 BLISTER 1683
63 PAIN IN EXTREMITY 1646
64 ABDOMINAL DISCOMFORT 1633
65 GENERALISED TONIC-CLONIC SEIZURE 1633
66 PRODUCT SUBSTITUTION ISSUE 1632
67 PRODUCT DOSE OMISSION ISSUE 1615
68 DEATH 1607
69 DRUG EXPOSURE DURING PREGNANCY 1607
70 VISION BLURRED 1604
71 IRRITABILITY 1603
72 GENERAL PHYSICAL HEALTH DETERIORATION 1584
73 GASTROOESOPHAGEAL REFLUX DISEASE 1579
74 PRODUCT USE ISSUE 1570
75 DRUG INTOLERANCE 1569
76 ABDOMINAL PAIN 1558
77 HYPOTENSION 1518
78 DRY MOUTH 1500
79 SLEEP DISORDER 1485
80 HEPATIC ENZYME INCREASED 1450
81 NASOPHARYNGITIS 1430
82 PRODUCT QUALITY ISSUE 1406
83 DISTURBANCE IN ATTENTION 1395
84 AMNESIA 1376
85 CONSTIPATION 1374
86 TOXIC EPIDERMAL NECROLYSIS 1345
87 MUSCULAR WEAKNESS 1343
88 SWELLING 1333
89 TYPE 2 DIABETES MELLITUS 1333
90 PERIPHERAL SWELLING 1305
91 COMA 1285
92 LYMPHADENOPATHY 1255
93 TREATMENT FAILURE 1251
94 C-REACTIVE PROTEIN INCREASED 1249
95 INTENTIONAL PRODUCT USE ISSUE 1241
96 BACK PAIN 1212
97 COUGH 1200
98 CHEST PAIN 1179
99 STOMATITIS 1177
100 BLOOD CHOLESTEROL INCREASED 1171
101 MANIA 1166
102 TACHYCARDIA 1163
103 SYSTEMIC LUPUS ERYTHEMATOSUS 1136
104 URINARY TRACT INFECTION 1136
105 GLOSSODYNIA 1126
106 COGNITIVE DISORDER 1125
107 JOINT SWELLING 1097
108 INFLAMMATION 1087
109 HALLUCINATION 1085
110 HYPERHIDROSIS 1083
111 DYSPEPSIA 1078
112 RHEUMATOID ARTHRITIS 1066
113 DRUG DOSE OMISSION 1063
114 MUSCULOSKELETAL STIFFNESS 1057
115 VERTIGO 1056
116 CARDIAC ARREST 1045
117 ANGER 1036
118 FIBROMYALGIA 1033
119 WOUND 1031
120 MYALGIA 1029
121 PERICARDITIS 1026
122 ABORTION SPONTANEOUS 1024
123 INFUSION RELATED REACTION 1019
124 PSORIATIC ARTHROPATHY 1014
125 OSTEOARTHRITIS 1013
126 ABNORMAL BEHAVIOUR 1012
127 CONTUSION 1012
128 BLEPHAROSPASM 997
129 WHEEZING 992
130 DYSPHAGIA 990
131 OBESITY 989
132 NECK PAIN 988
133 STATUS EPILEPTICUS 986
134 VISUAL IMPAIRMENT 986
135 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 979
136 RASH MACULO-PAPULAR 977
137 MOBILITY DECREASED 974
138 ATAXIA 968
139 ILL-DEFINED DISORDER 968
140 DYSKINESIA 967
141 PEMPHIGUS 967
142 ARTHROPATHY 957
143 INJURY 948
144 SYNOVITIS 938
145 DRUG ABUSE 936
146 LIVE BIRTH 934
147 ABDOMINAL DISTENSION 931
148 DIPLOPIA 931
149 NIGHT SWEATS 928
150 ADVERSE DRUG REACTION 924
151 BURSITIS 917
152 HAND DEFORMITY 916
153 DEPRESSED MOOD 912
154 INCORRECT DOSE ADMINISTERED 910
155 IRRITABLE BOWEL SYNDROME 909
156 GASTROINTESTINAL DISORDER 903
157 DRUG ERUPTION 900
158 LETHARGY 899
159 HOSPITALISATION 892
160 FOLLICULITIS 890
161 ACUTE KIDNEY INJURY 888
162 SPEECH DISORDER 884
163 INTENTIONAL SELF-INJURY 880
164 SEDATION 880
165 TASTE DISORDER 876
166 BREAST CANCER STAGE III 873
167 IMPAIRED HEALING 873
168 DUODENAL ULCER PERFORATION 869
169 DYSARTHRIA 864
170 LIVER INJURY 863
171 BIPOLAR DISORDER 857
172 PSYCHOTIC DISORDER 854
173 LOWER RESPIRATORY TRACT INFECTION 852
174 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 846
175 DEPRESSED LEVEL OF CONSCIOUSNESS 843
176 HELICOBACTER INFECTION 842
177 MUSCULOSKELETAL PAIN 842
178 OROPHARYNGEAL PAIN 839
179 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 836
180 LUNG DISORDER 832
181 OEDEMA PERIPHERAL 829
182 DEHYDRATION 821
183 RASH ERYTHEMATOUS 812
184 DRUG LEVEL INCREASED 808
185 CRYING 807
186 RESTLESSNESS 807
187 WOUND INFECTION 804
188 CONTRAINDICATED PRODUCT ADMINISTERED 802
189 ANAEMIA 800
190 RASH GENERALISED 796
191 FACET JOINT SYNDROME 795
192 DRUG-INDUCED LIVER INJURY 793
193 CARDIO-RESPIRATORY ARREST 790
194 MENTAL DISORDER 789
195 TREATMENT NONCOMPLIANCE 789
196 THERAPEUTIC PRODUCT EFFECT DECREASED 787
197 THROMBOCYTOPENIA 787
198 ADVERSE EVENT 785
199 GAIT INABILITY 785
200 PALPITATIONS 780
201 JOINT RANGE OF MOTION DECREASED 778
202 HYPONATRAEMIA 775
203 DISORIENTATION 759
204 MOOD SWINGS 759
205 SEROTONIN SYNDROME 755
206 ELECTROCARDIOGRAM QT PROLONGED 746
207 SKIN EXFOLIATION 745
208 LIP DRY 744
209 MUSCLE INJURY 744
210 CHILLS 741
211 ALANINE AMINOTRANSFERASE INCREASED 735
212 WITHDRAWAL SYNDROME 735
213 HYPERCHOLESTEROLAEMIA 733
214 NAIL DISORDER 723
215 PANIC ATTACK 723
216 STRESS 715
217 UNDERDOSE 714
218 BLOOD PRESSURE INCREASED 700
219 PETIT MAL EPILEPSY 700
220 MEDICATION ERROR 699
221 BACK INJURY 695
222 COVID-19 682
223 SINUSITIS 682
224 RENAL FAILURE 681
225 INFECTION 680
226 WHITE BLOOD CELL COUNT DECREASED 680
227 PERIPHERAL VENOUS DISEASE 674
228 RASH PRURITIC 672
229 ONYCHOMADESIS 671
230 INTENTIONAL PRODUCT MISUSE 659
231 HEART RATE INCREASED 650
232 SYNCOPE 648
233 GRAND MAL CONVULSION 642
234 DELIRIUM 641
235 DIABETES MELLITUS 633
236 ASTHMA 631
237 NEUTROPENIA 628
238 APHASIA 624
239 INJECTION SITE PAIN 620
240 SWELLING FACE 615
241 INFLUENZA LIKE ILLNESS 612
242 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 606
243 LIVER FUNCTION TEST INCREASED 599
244 MUSCLE TWITCHING 593
245 NIGHTMARE 593
246 EMOTIONAL DISTRESS 592
247 MOOD ALTERED 589
248 ATRIAL SEPTAL DEFECT 583
249 ASPARTATE AMINOTRANSFERASE INCREASED 580
250 DISCOMFORT 578
251 DRUG WITHDRAWAL SYNDROME 577
252 RHABDOMYOLYSIS 576
253 PARTIAL SEIZURES 563
254 ALTERED STATE OF CONSCIOUSNESS 562
255 HYPERSOMNIA 557
256 MYOCLONUS 553
257 MENTAL IMPAIRMENT 552
258 MULTIPLE-DRUG RESISTANCE 547
259 LEUKOPENIA 545
260 SEPSIS 545
261 HEPATITIS 544
262 INJECTION SITE REACTION 540
263 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 538
264 PREMATURE BABY 536
265 COORDINATION ABNORMAL 535
266 RHEUMATIC FEVER 529
267 INFLUENZA 526
268 ROAD TRAFFIC ACCIDENT 524
269 TARDIVE DYSKINESIA 522
270 ENCEPHALOPATHY 520
271 CEREBROVASCULAR ACCIDENT 517
272 GRIP STRENGTH DECREASED 515
273 BRADYCARDIA 514
274 FLUSHING 513
275 PANCREATITIS 511
276 OEDEMA 510
277 NERVOUSNESS 506
278 HALLUCINATION, AUDITORY 501
279 MOUTH ULCERATION 500
280 BURNING SENSATION 499
281 BLOOD GLUCOSE INCREASED 498
282 PLATELET COUNT DECREASED 497
283 CHEST DISCOMFORT 493
284 RASH MACULAR 493
285 CONGENITAL ANOMALY 490
286 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 489
287 FEELING HOT 488
288 THINKING ABNORMAL 484
289 HEAD INJURY 483
290 WHITE BLOOD CELL COUNT INCREASED 482
291 THERAPEUTIC RESPONSE UNEXPECTED 481
292 BRONCHITIS 479
293 ILLNESS 479
294 ONYCHOMYCOSIS 477
295 HEPATIC FUNCTION ABNORMAL 472
296 AKATHISIA 465
297 PARANOIA 465
298 PRESCRIBED OVERDOSE 463
299 TINNITUS 462
300 NYSTAGMUS 460
301 THERAPEUTIC RESPONSE DECREASED 459
302 DRUG RESISTANCE 458
303 DYSGEUSIA 457
304 NO ADVERSE EVENT 453
305 UNRESPONSIVE TO STIMULI 450
306 PSYCHOMOTOR HYPERACTIVITY 446
307 BLOOD CREATINE PHOSPHOKINASE INCREASED 443
308 PREGNANCY 443
309 THERAPY NON-RESPONDER 443
310 RESPIRATORY FAILURE 439
311 HALLUCINATION, VISUAL 438
312 CHRONIC KIDNEY DISEASE 437
313 URINARY INCONTINENCE 437
314 MENTAL STATUS CHANGES 435
315 NEUROLEPTIC MALIGNANT SYNDROME 432
316 LIVER DISORDER 431
317 C-REACTIVE PROTEIN ABNORMAL 428
318 DELUSION 428
319 FACE OEDEMA 428
320 OBSESSIVE-COMPULSIVE DISORDER 427
321 EOSINOPHILIA 426
322 ACCIDENTAL OVERDOSE 425
323 PSORIASIS 425
324 DRY SKIN 423
325 EMOTIONAL DISORDER 422
326 ADVERSE REACTION 419
327 UNEVALUABLE EVENT 418
328 NEUROPATHY PERIPHERAL 415
329 COELIAC DISEASE 412
330 RESPIRATORY ARREST 412
331 MATERNAL DRUGS AFFECTING FOETUS 407
332 URINARY RETENTION 405
333 PULMONARY EMBOLISM 401
334 LIP SWELLING 398
335 EXTRAPYRAMIDAL DISORDER 397
336 OXYGEN SATURATION DECREASED 397
337 OCULAR HYPERAEMIA 396
338 RASH PAPULAR 394
339 BLOOD PRESSURE DECREASED 391
340 PANCYTOPENIA 391
341 PHOTOPHOBIA 388
342 ERYTHEMA MULTIFORME 387
343 FEAR 387
344 CONJUNCTIVITIS 384
345 HAEMOGLOBIN DECREASED 384
346 VENTRICULAR SEPTAL DEFECT 382
347 PNEUMONIA ASPIRATION 380
348 SLEEP APNOEA SYNDROME 379
349 DRUG ADMINISTRATION ERROR 377
350 SURGERY 376
351 OSTEOPOROSIS 373
352 EYE PAIN 372
353 SKIN DISORDER 371
354 PRESCRIBED UNDERDOSE 370
355 DISEASE RECURRENCE 369
356 SKIN LESION 369
357 ABNORMAL DREAMS 366
358 SWOLLEN TONGUE 364
359 DRUG DEPENDENCE 362
360 MYOCARDIAL INFARCTION 361
361 ACNE 360
362 APATHY 360
363 GAMMA-GLUTAMYLTRANSFERASE INCREASED 359
364 HYPOKALAEMIA 358
365 DYSTONIA 355
366 SKIN DISCOLOURATION 354
367 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 353
368 DRUG LEVEL DECREASED 351
369 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 351
370 RENAL IMPAIRMENT 349
371 UPPER RESPIRATORY TRACT INFECTION 348
372 HOT FLUSH 347
373 NEPHROLITHIASIS 347
374 HYPOMANIA 345
375 POISONING DELIBERATE 342
376 RESTLESS LEGS SYNDROME 338
377 THERAPY CESSATION 338
378 MOVEMENT DISORDER 337
379 PRODUCT DOSE OMISSION 337
380 ARTHRITIS 335
381 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 333
382 INCREASED APPETITE 331
383 ECZEMA 329
384 POISONING 329
385 FINGER DEFORMITY 327
386 TOXIC SKIN ERUPTION 327
387 DRY EYE 323
388 HYPOTHYROIDISM 322
389 HAEMORRHAGE 321
390 POOR QUALITY SLEEP 321
391 PRODUCT LABEL CONFUSION 320
392 SINUS TACHYCARDIA 318
393 EAR PAIN 316
394 BLOOD CREATININE INCREASED 315
395 MULTIPLE SCLEROSIS RELAPSE 315
396 MYDRIASIS 314
397 RHINORRHOEA 313
398 EPISTAXIS 311
399 ARRHYTHMIA 308
400 METABOLIC ACIDOSIS 308
401 DRUG EFFECT DECREASED 306
402 TRANSAMINASES INCREASED 306
403 IMPAIRED WORK ABILITY 303
404 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 302
405 DYSURIA 295
406 LIVER FUNCTION TEST ABNORMAL 294
407 SUSPECTED SUICIDE 292
408 ABORTION INDUCED 291
409 EATING DISORDER 289
410 MULTIPLE ORGAN DYSFUNCTION SYNDROME 289
411 AFFECTIVE DISORDER 285
412 AURA 285
413 CAESAREAN SECTION 284
414 HYPERTHERMIA 282
415 RESPIRATORY DISORDER 282
416 HYPOGLYCAEMIA 281
417 SOPOR 281
418 BODY TEMPERATURE INCREASED 278
419 DYSPHONIA 278
420 MUSCLE RIGIDITY 276
421 HYPOTONIA 274
422 LEUKOCYTOSIS 274
423 POLLAKIURIA 274
424 THERAPY INTERRUPTED 274
425 BEHAVIOUR DISORDER 273
426 CARDIAC DISORDER 272
427 MIDDLE INSOMNIA 272
428 DISABILITY 268
429 DISSEMINATED INTRAVASCULAR COAGULATION 267
430 PARKINSONISM 266
431 CELLULITIS 265
432 ORAL PAIN 263
433 HEPATIC FAILURE 262
434 PHOTOSENSITIVITY REACTION 260
435 NERVOUS SYSTEM DISORDER 259
436 VISUAL ACUITY REDUCED 258
437 DISSOCIATION 257
438 NASAL CONGESTION 257
439 GENERALISED ERYTHEMA 256
440 PLEURAL EFFUSION 253
441 ANAPHYLACTIC REACTION 252
442 AGRANULOCYTOSIS 251
443 DRUG DISPENSING ERROR 250
444 THROAT TIGHTNESS 250
445 LOWER LIMB FRACTURE 249
446 BLOOD ALKALINE PHOSPHATASE INCREASED 248
447 RESPIRATORY DISTRESS 248
448 THROMBOSIS 246
449 NEUTROPHIL COUNT DECREASED 244
450 ORAL MUCOSA EROSION 244
451 SHOCK 244
452 WRONG TECHNIQUE IN DRUG USAGE PROCESS 244
453 EYE SWELLING 243
454 ANHEDONIA 242
455 INJECTION SITE ERYTHEMA 242
456 INFUSION SITE REACTION 241
457 PATENT DUCTUS ARTERIOSUS 241
458 VIRAL INFECTION 241
459 DYSSTASIA 240
460 EXOSTOSIS 240
461 FLATULENCE 240
462 BLINDNESS 239
463 SALIVARY HYPERSECRETION 238
464 EAR INFECTION 237
465 HEPATOCELLULAR INJURY 237
466 DEEP VEIN THROMBOSIS 234
467 FEELING DRUNK 234
468 SKIN BURNING SENSATION 234
469 ATRIAL FIBRILLATION 233
470 ELECTROENCEPHALOGRAM ABNORMAL 233
471 MAJOR DEPRESSION 233
472 SEPTIC SHOCK 231
473 MULTIPLE SCLEROSIS 230
474 AFFECT LABILITY 228
475 EYE DISORDER 228
476 BONE PAIN 227
477 DYSMORPHISM 227
478 LIP EROSION 227
479 EYE IRRITATION 226
480 HYPOSPADIAS 226
481 CATARACT 225
482 INFARCTION 223
483 NORMAL NEWBORN 223
484 VAGINAL HAEMORRHAGE 223
485 JAUNDICE 222
486 CHOLESTASIS 221
487 CONJUNCTIVAL HYPERAEMIA 221
488 HYPOPHAGIA 221
489 PALLOR 221
490 PRODUCT ADMINISTRATION INTERRUPTED 221
491 DRUG TOXICITY 220
492 CROHN^S DISEASE 218
493 EXPOSURE VIA BREAST MILK 218
494 MYOCLONIC EPILEPSY 218
495 RETCHING 218
496 RED BLOOD CELL SEDIMENTATION RATE INCREASED 217
497 FOOT FRACTURE 215
498 ACUTE RESPIRATORY DISTRESS SYNDROME 214
499 ANGIOEDEMA 214
500 ACTIVITIES OF DAILY LIVING IMPAIRED 212
501 PRE-EXISTING CONDITION IMPROVED 212
502 SCAR 212
503 STAPHYLOCOCCAL INFECTION 212
504 MENINGITIS ASEPTIC 211
505 RENAL DISORDER 211
506 RENAL FAILURE ACUTE 211
507 BLOOD LACTATE DEHYDROGENASE INCREASED 210
508 EYE MOVEMENT DISORDER 208
509 DEMENTIA 207
510 DISLOCATION OF VERTEBRA 207
511 ERECTILE DYSFUNCTION 207
512 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 207
513 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 207
514 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 207
515 PREMATURE DELIVERY 206
516 BLOOD SODIUM DECREASED 205
517 SCIATICA 205
518 DEVELOPMENTAL DELAY 204
519 HYPOXIA 204
520 MATERNAL EXPOSURE DURING BREAST FEEDING 204
521 PRODUCT PRESCRIBING ERROR 203
522 SPINA BIFIDA 203
523 DRUG SCREEN POSITIVE 201
524 RECTAL HAEMORRHAGE 201
525 TALIPES 200
526 EUPHORIC MOOD 199
527 HYPERGLYCAEMIA 199
528 JOINT STIFFNESS 199
529 CONCUSSION 198
530 HYPERREFLEXIA 198
531 RASH VESICULAR 198
532 FEELING JITTERY 197
533 IMPAIRED DRIVING ABILITY 197
534 SCHIZOPHRENIA 197
535 ABASIA 196
536 BLOOD POTASSIUM DECREASED 196
537 ANTICONVULSANT DRUG LEVEL DECREASED 195
538 ECONOMIC PROBLEM 195
539 HEPATIC STEATOSIS 195
540 HERPES ZOSTER 194
541 PSYCHIATRIC SYMPTOM 194
542 RIB FRACTURE 194
543 HYPOGAMMAGLOBULINAEMIA 193
544 PRURITUS GENERALISED 193
545 THIRST 193
546 FLUID RETENTION 192
547 RESPIRATORY DEPRESSION 192
548 SMALL FOR DATES BABY 192
549 DISEASE PROGRESSION 191
550 PERSONALITY CHANGE 191
551 PHARMACEUTICAL PRODUCT COMPLAINT 191
552 DROOLING 190
553 RED BLOOD CELL COUNT DECREASED 189
554 DRUG EFFECT INCOMPLETE 188
555 LARYNGITIS 188
556 ACUTE HEPATIC FAILURE 187
557 BIPOLAR I DISORDER 187
558 CARDIAC FAILURE 186
559 ANTICONVULSANT DRUG LEVEL INCREASED 185
560 FREQUENT BOWEL MOVEMENTS 185
561 FOCAL DYSCOGNITIVE SEIZURES 184
562 LIMB DISCOMFORT 184
563 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 183
564 JOINT INJURY 183
565 LUPUS-LIKE SYNDROME 183
566 GASTROINTESTINAL HAEMORRHAGE 182
567 INTENTIONAL DRUG MISUSE 182
568 MOTOR DYSFUNCTION 182
569 PURPURA 182
570 SCAB 182
571 CIRCULATORY COLLAPSE 181
572 ORAL DISORDER 181
573 BRAIN FOG 180
574 RASH MORBILLIFORM 180
575 TIC 180
576 ACCIDENTAL EXPOSURE TO PRODUCT 179
577 INTENTIONAL DOSE OMISSION 179
578 INTESTINAL OBSTRUCTION 179
579 CHEILITIS 178
580 MUSCLE TIGHTNESS 178
581 SEXUAL DYSFUNCTION 178
582 HYPERTONIA 177
583 SUICIDAL BEHAVIOUR 177
584 IMPAIRED GASTRIC EMPTYING 176
585 INJECTION SITE BRUISING 176
586 PSYCHOMOTOR RETARDATION 175
587 BLOOD TRIGLYCERIDES INCREASED 174
588 COMPLEX PARTIAL SEIZURES 173
589 INITIAL INSOMNIA 173
590 PRODUCT DISPENSING ERROR 173
591 INTERVERTEBRAL DISC PROTRUSION 172
592 TACHYPHRENIA 172
593 CHOKING 171
594 METRORRHAGIA 171
595 PRODUCT ADMINISTRATION ERROR 171
596 HAEMATOCHEZIA 170
597 HYPERAMMONAEMIA 170
598 LIMB INJURY 170
599 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 170
600 AUTOIMMUNE DISORDER 169
601 BRAIN OEDEMA 169
602 DERMATITIS ALLERGIC 169
603 DERMATITIS ATOPIC 169
604 LOGORRHOEA 168
605 CYSTITIS 167
606 INJECTION SITE SWELLING 167
607 NEURALGIA 167
608 AUTISM SPECTRUM DISORDER 166
609 BLOOD BILIRUBIN INCREASED 166
610 DEVICE ISSUE 166
611 PHARYNGEAL OEDEMA 166
612 NEONATAL RESPIRATORY DISTRESS SYNDROME 165
613 PRODUCT AVAILABILITY ISSUE 165
614 PULMONARY FIBROSIS 164
615 TRANSIENT ISCHAEMIC ATTACK 164
616 FEELING COLD 163
617 MYOCARDITIS 163
618 SOMNAMBULISM 163
619 TUBULOINTERSTITIAL NEPHRITIS 163
620 FEEDING DISORDER 162
621 SUDDEN DEATH 162
622 HYPOKINESIA 161
623 MULTI-ORGAN FAILURE 161
624 ORAL MUCOSAL BLISTERING 161
625 UPPER LIMB FRACTURE 161
626 HYPOACUSIS 160
627 POST-TRAUMATIC STRESS DISORDER 160
628 TACHYPNOEA 159
629 ASPIRATION 158
630 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 158
631 BRUXISM 158
632 RESPIRATORY DISORDER NEONATAL 158
633 DERMATITIS 157
634 APNOEA 156
635 CATATONIA 156
636 CHOLELITHIASIS 156
637 PAPULE 156
638 PRODUCTIVE COUGH 156
639 WRONG PATIENT RECEIVED PRODUCT 156
640 CYANOSIS 155
641 HEART RATE DECREASED 155
642 MENORRHAGIA 155
643 MENSTRUATION IRREGULAR 155
644 PANCREATITIS ACUTE 155
645 SENSORY DISTURBANCE 155
646 VENTRICULAR TACHYCARDIA 155
647 EYE DISCHARGE 154
648 INTERSTITIAL LUNG DISEASE 154
649 HEPATIC CIRRHOSIS 153
650 PHARYNGITIS 153
651 SWOLLEN JOINT COUNT INCREASED 153
652 CLEFT PALATE 152
653 DEPRESSIVE SYMPTOM 152
654 INTERNATIONAL NORMALISED RATIO INCREASED 152
655 LIBIDO DECREASED 152
656 PULMONARY OEDEMA 152
657 GASTRIC DISORDER 151
658 HEMIPARESIS 151
659 HYPOTHERMIA 151
660 IMPULSIVE BEHAVIOUR 151
661 OCULOGYRIC CRISIS 151
662 CLONUS 150
663 EYE PRURITUS 150
664 EYELID OEDEMA 149
665 GESTATIONAL DIABETES 149
666 STILLBIRTH 149
667 THROAT IRRITATION 149
668 HAEMATOCRIT DECREASED 148
669 CENTRAL NERVOUS SYSTEM LESION 147
670 GAMBLING DISORDER 147
671 HUNGER 147
672 INSURANCE ISSUE 147
673 LOCAL SWELLING 147
674 OSTEOPENIA 147
675 FUNGAL INFECTION 146
676 GASTRITIS 146
677 INCONTINENCE 146
678 JOINT DISLOCATION 146
679 SOCIAL AVOIDANT BEHAVIOUR 146
680 CHROMATURIA 145
681 NEUROTOXICITY 145
682 PARALYSIS 145
683 STARING 145
684 ANTIPSYCHOTIC DRUG LEVEL INCREASED 143
685 GASTROENTERITIS VIRAL 143
686 QUALITY OF LIFE DECREASED 143
687 RHEUMATOID FACTOR POSITIVE 143
688 ANOREXIA 142
689 DERMATITIS EXFOLIATIVE 142
690 DRUG SCREEN FALSE POSITIVE 142
691 HYPERNATRAEMIA 142
692 RESPIRATORY TRACT INFECTION 142
693 SKIN REACTION 142
694 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 142
695 TONIC CONVULSION 142
696 VENTRICULAR FIBRILLATION 142
697 BRAIN INJURY 141
698 BREAST CANCER 141
699 EOSINOPHIL COUNT INCREASED 141
700 HAEMATOMA 141
701 KNEE ARTHROPLASTY 141
702 CEREBRAL ATROPHY 140
703 HIP FRACTURE 140
704 PREMATURE LABOUR 140
705 BLOOD PROLACTIN INCREASED 139
706 INJECTION SITE HAEMORRHAGE 139
707 SCREAMING 139
708 DEAFNESS 138
709 DRUG PRESCRIBING ERROR 138
710 DRUG TOLERANCE 138
711 ANKLE FRACTURE 137
712 COLD SWEAT 137
713 PRESYNCOPE 137
714 PRODUCT PRESCRIBING ISSUE 137
715 DEVICE DISLOCATION 136
716 ENURESIS 136
717 LABORATORY TEST ABNORMAL 136
718 UNINTENDED PREGNANCY 136
719 DEEP VEIN THROMBOSIS POSTOPERATIVE 135
720 INCORRECT PRODUCT ADMINISTRATION DURATION 135
721 INJECTION SITE PRURITUS 135
722 LACRIMATION INCREASED 135
723 LUPUS VULGARIS 135
724 NEUTROPHIL COUNT INCREASED 135
725 BLOOD GLUCOSE DECREASED 134
726 LOW BIRTH WEIGHT BABY 134
727 AMENORRHOEA 133
728 CEREBRAL HAEMORRHAGE 133
729 DECREASED INTEREST 133
730 HYPERLIPIDAEMIA 133
731 LYMPHOPENIA 133
732 ODYNOPHAGIA 133
733 PERICARDIAL EFFUSION 133
734 BEDRIDDEN 132
735 CLUMSINESS 132
736 DIABETES MELLITUS INADEQUATE CONTROL 132
737 HYPOAESTHESIA ORAL 132
738 OVERLAP SYNDROME 132
739 ANURIA 131
740 BRADYPHRENIA 131
741 DERMATITIS BULLOUS 131
742 HEPATIC CYTOLYSIS 131
743 SKIN ULCER 131
744 HAEMODYNAMIC INSTABILITY 130
745 MATERNAL EXPOSURE BEFORE PREGNANCY 130
746 ORTHOSTATIC HYPOTENSION 130
747 TOOTH DISORDER 130
748 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 129
749 CEREBRAL DISORDER 129
750 PERIPHERAL COLDNESS 129
751 ACUTE RESPIRATORY FAILURE 128
752 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 127
753 BONE EROSION 127
754 BREAST CANCER STAGE II 127
755 ULCER HAEMORRHAGE 127
756 ABDOMINAL PAIN LOWER 126
757 CARDIAC FAILURE CONGESTIVE 126
758 HAEMATURIA 126
759 INABILITY TO AFFORD MEDICATION 126
760 PERSONALITY DISORDER 126
761 PHARYNGOLARYNGEAL PAIN 126
762 DEVICE EXPULSION 125
763 DIABETIC KETOACIDOSIS 125
764 MIOSIS 125
765 SELF-INJURIOUS IDEATION 125
766 THERAPY PARTIAL RESPONDER 124
767 HEAD DISCOMFORT 123
768 SKIN EROSION 123
769 SPEECH DISORDER DEVELOPMENTAL 123
770 ATONIC SEIZURES 122
771 NEOPLASM MALIGNANT 122
772 PAIN IN JAW 122
773 PARADOXICAL DRUG REACTION 122
774 SELECTIVE EATING DISORDER 122
775 SLUGGISHNESS 122
776 VITAMIN D DEFICIENCY 122
777 PARAESTHESIA ORAL 120
778 PETECHIAE 120
779 FOETAL GROWTH RESTRICTION 119
780 RASH PUSTULAR 119
781 TONGUE DISORDER 119
782 BACK DISORDER 118
783 BRAIN OPERATION 118
784 CEREBELLAR SYNDROME 118
785 STRABISMUS 118
786 DEVICE MALFUNCTION 117
787 HEPATOMEGALY 117
788 LYMPHOCYTE COUNT DECREASED 117
789 THERAPEUTIC RESPONSE CHANGED 117
790 DENTAL CARIES 116
791 ERYTHEMA OF EYELID 116
792 HEART RATE IRREGULAR 116
793 MENSTRUAL DISORDER 116
794 PARKINSON^S DISEASE 116
795 COLITIS 115
796 FEELING OF DESPAIR 115
797 HOSTILITY 115
798 INJECTION SITE MASS 115
799 RESPIRATORY ACIDOSIS 115
800 CARDIOGENIC SHOCK 114
801 EXPIRED PRODUCT ADMINISTERED 114
802 EXPOSURE DURING BREAST FEEDING 114
803 HOMICIDAL IDEATION 114
804 HYPOCHOLESTEROLAEMIA 114
805 HALLUCINATIONS, MIXED 113
806 EXTRA DOSE ADMINISTERED 112
807 HYPOTONIA NEONATAL 112
808 PRE-ECLAMPSIA 112
809 TENDERNESS 112
810 DRUG WITHDRAWAL SYNDROME NEONATAL 111
811 FEBRILE NEUTROPENIA 111
812 HAEMATEMESIS 111
813 KIDNEY INFECTION 111
814 PSYCHOMOTOR SKILLS IMPAIRED 111
815 TOOTHACHE 111
816 ANXIETY DISORDER 110
817 COLITIS ULCERATIVE 110
818 GAZE PALSY 110
819 MUCOSAL INFLAMMATION 110
820 SPLENOMEGALY 110
821 VISUAL DISTURBANCE 110
822 X-RAY ABNORMAL 110
823 CANDIDA INFECTION 109
824 DRUG TITRATION ERROR 109
825 GALLBLADDER DISORDER 109
826 HERNIA 109
827 HIP ARTHROPLASTY 109
828 HYPERVENTILATION 109
829 INTELLECTUAL DISABILITY 109
830 ORAL DISCOMFORT 109
831 SUBSTANCE ABUSE 109
832 THERAPEUTIC RESPONSE SHORTENED 109
833 ULCER 109
834 AGEUSIA 108
835 CARDIAC MURMUR 108
836 CARPAL TUNNEL SYNDROME 108
837 COMA SCALE ABNORMAL 108
838 DYSPHORIA 108
839 DEVICE BREAKAGE 107
840 DRUG WITHDRAWAL CONVULSIONS 107
841 OVERWEIGHT 107
842 PANIC REACTION 107
843 PLATELET COUNT INCREASED 107
844 POLYDACTYLY 107
845 BACTERIAL INFECTION 106
846 PRODUCT DOSE OMISSION IN ERROR 106
847 PRODUCT PHYSICAL ISSUE 106
848 SNEEZING 106
849 INCREASED TENDENCY TO BRUISE 105
850 MUSCLE SPASTICITY 105
851 SINUS BRADYCARDIA 105
852 SNORING 105
853 THERAPY CHANGE 105
854 COAGULOPATHY 104
855 DYSPNOEA EXERTIONAL 104
856 FOOT DEFORMITY 104
857 RENAL INJURY 104
858 SUBDURAL HAEMATOMA 104
859 BUNDLE BRANCH BLOCK RIGHT 103
860 HYPERPHAGIA 103
861 LACTIC ACIDOSIS 103
862 APPETITE DISORDER 102
863 ELECTROCARDIOGRAM ABNORMAL 102
864 FOETAL ANTICONVULSANT SYNDROME 102
865 HYPERACUSIS 102
866 INCOHERENT 102
867 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 102
868 RETINITIS 102
869 STUPOR 102
870 IMPAIRED QUALITY OF LIFE 101
871 ACIDOSIS 100
872 BRADYKINESIA 100
873 COMPULSIVE SHOPPING 100
874 DEVELOPMENTAL HIP DYSPLASIA 100
875 DYSPHEMIA 100
876 MICROCEPHALY 100
877 OBSESSIVE THOUGHTS 100
878 OSTEONECROSIS 100
879 PRODUCT COMPLAINT 100
880 ATTENTION DEFICIT HYPERACTIVITY DISORDER 99
881 DERMATITIS CONTACT 99
882 DYSMENORRHOEA 99
883 PROCEDURAL PAIN 99
884 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 98
885 BLOOD PRESSURE FLUCTUATION 98
886 BRUGADA SYNDROME 98
887 DYSGRAPHIA 98
888 GRANULOCYTOPENIA 98
889 HYPERKALAEMIA 98
890 PAIN OF SKIN 98
891 PERSECUTORY DELUSION 98
892 PIGMENTATION DISORDER 98
893 VISUAL FIELD DEFECT 98
894 AGITATION NEONATAL 97
895 AMMONIA INCREASED 97
896 DRUG LEVEL BELOW THERAPEUTIC 97
897 MALIGNANT NEOPLASM PROGRESSION 97
898 PLEUROTHOTONUS 97
899 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 96
900 CLEFT LIP AND PALATE 96
901 DECREASED ACTIVITY 96
902 SINUS DISORDER 96
903 SKIN WARM 96
904 SPINAL FRACTURE 96
905 TEMPERATURE INTOLERANCE 96
906 WALKING AID USER 96
907 ENERGY INCREASED 95
908 MICTURITION URGENCY 95
909 POSTURE ABNORMAL 95
910 TOOTH FRACTURE 95
911 ANGINA PECTORIS 94
912 HEPATOTOXICITY 94
913 NO THERAPEUTIC RESPONSE 94
914 SKIN IRRITATION 94
915 TONGUE BITING 94
916 GYNAECOMASTIA 93
917 PERFORMANCE STATUS DECREASED 93
918 POLYDIPSIA 93
919 MUCOUS MEMBRANE DISORDER 92
920 MUSCLE ATROPHY 92
921 PAROSMIA 92
922 PELVIC PAIN 92
923 SEIZURE CLUSTER 92
924 TOOTH LOSS 92
925 WRIST FRACTURE 92
926 ATELECTASIS 91
927 BLOOD PRESSURE ABNORMAL 91
928 DRUG LEVEL ABOVE THERAPEUTIC 91
929 FEEDING DISORDER NEONATAL 91
930 THERMAL BURN 91
931 APLASTIC ANAEMIA 90
932 MUSCULOSKELETAL DISCOMFORT 90
933 PRODUCT USE COMPLAINT 90
934 SEASONAL ALLERGY 90
935 BEZOAR 89
936 CLOSTRIDIUM DIFFICILE INFECTION 89
937 COARCTATION OF THE AORTA 89
938 FLAT AFFECT 89
939 IMPULSE-CONTROL DISORDER 89
940 LOCALISED INFECTION 89
941 LOSS OF EMPLOYMENT 89
942 NOCTURIA 89
943 SJS-TEN OVERLAP 89
944 BRADYCARDIA NEONATAL 88
945 EXCESSIVE EYE BLINKING 88
946 GLAUCOMA 88
947 HAIR TEXTURE ABNORMAL 88
948 HEART DISEASE CONGENITAL 88
949 MENINGITIS 88
950 ORAL CANDIDIASIS 88
951 PRODUCT TASTE ABNORMAL 88
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 87
953 CYST 87
954 FRACTURE 87
955 LIBIDO INCREASED 87
956 MATERNAL EXPOSURE TIMING UNSPECIFIED 87
957 SKIN FISSURES 87
958 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 86
959 ASCITES 86
960 CHANGE IN SEIZURE PRESENTATION 86
961 HYPOCALCAEMIA 86
962 VENTRICULAR EXTRASYSTOLES 86
963 ABNORMAL WEIGHT GAIN 85
964 FOETAL MALFORMATION 85
965 FORMICATION 85
966 TRISMUS 85
967 ACCIDENT 84
968 BONE MARROW FAILURE 84
969 CARDIOMYOPATHY 84
970 ELECTROLYTE IMBALANCE 84
971 FACIAL PAIN 84
972 LIGAMENT SPRAIN 84
973 PSYCHOTIC SYMPTOM 84
974 ALCOHOL ABUSE 83
975 ANAL INCONTINENCE 83
976 ENANTHEMA 83
977 FAECES DISCOLOURED 83
978 HYPOALBUMINAEMIA 83
979 MALNUTRITION 83
980 MULTIPLE CONGENITAL ABNORMALITIES 83
981 NERVE COMPRESSION 83
982 NEUROLOGICAL SYMPTOM 83
983 THYROID DISORDER 83
984 ATRIOVENTRICULAR BLOCK 82
985 BLOOD UREA INCREASED 82
986 HYPERTHYROIDISM 82
987 IMMUNE SYSTEM DISORDER 82
988 IMMUNODEFICIENCY 82
989 ORAL HERPES 82
990 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 82
991 PHARYNGITIS STREPTOCOCCAL 82
992 POST PROCEDURAL COMPLICATION 82
993 SIMPLE PARTIAL SEIZURES 82
994 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 82
995 TOXIC ENCEPHALOPATHY 82
996 ATRIOVENTRICULAR BLOCK COMPLETE 81
997 DIABETIC NEUROPATHY 81
998 GALACTORRHOEA 81
999 GENERALISED OEDEMA 81